Personalis

Personalis Liabilities

The The Liabilities of Personalis (PSNL) as of Nov 11, 2026 is 72.98 M USD. In the previous year, The Liabilities was 67.31 M USD — a change of 8.42% (higher).

Liabilities

72.98 MUSD

YoY

8.42%

Last updated:

In 2025, Personalis's total liabilities amounted to 72.98 M USD, a 8.42% difference from the 67.31 M USD total liabilities in the previous year.

The Personalis Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
148.06 M USD
Jan 1, 2019
50.60 M USD
Jan 1, 2020
49.90 M USD
Jan 1, 2021
86.23 M USD
Jan 1, 2022
74.56 M USD
Jan 1, 2023
95.66 M USD
Jan 1, 2024
67.31 M USD
Jan 1, 2025
72.98 M USD
The Personalis Liabilities history
YEARLiabilitiesYoY
72.98 MUSD+8.42%
67.31 MUSD-29.63%
95.66 MUSD+28.29%
74.56 MUSD-13.53%
86.23 MUSD+72.81%
49.90 MUSD-1.39%
50.60 MUSD-65.82%
148.06 MUSD+17.35%
126.17 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Personalis Stock analysis

What does Personalis do? Personalis Inc is a diagnostic company specializing in the development of tests for personalized medicine. The company was founded in 2011 by Dr. Richard Chen and Dr. Erin Newburn and is headquartered in Menlo Park, California. They initially focused on developing genomic tools for cancer diagnosis and treatment but have expanded their offerings to include tests for rare genetic diseases, immunotherapies, and precision oncology drugs. They work closely with pharmaceutical and biotechnology companies as well as academics to develop innovative therapeutic approaches. Their business model is based on making genomics biology usable for personalized medicine and clinical research. They have a wide portfolio of genomic-based solutions for personalized medicine, including tests for tumor mutations, tumor-specific neoantigens, rare genetic diseases, and personalized immunotherapy. They also offer customized genomic solutions for pharmaceutical and biotechnology companies. Personalis Inc aims to establish personalized medicine quickly and effectively to provide the best possible outcome for patients. Personalis is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Personalis's Liabilities

Personalis's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Personalis's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Personalis's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Personalis's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Personalis’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Personalis stock

The Liabilities of Personalis is 72.98 M USD in 2025.

The Liabilities of Personalis changed from 67.31 M USD to 72.98 M USD, representing a 8.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Personalis since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Personalis historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Personalis

All Key Metrics — Personalis